151 related articles for article (PubMed ID: 37025259)
41. FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma: A Comparative Prognostic Analysis.
Parra-Herran C; Bassiouny D; Vicus D; Olkhov-Mitsel E; Cesari M; Ismiil N; Nofech-Mozes S
Am J Surg Pathol; 2019 Feb; 43(2):161-167. PubMed ID: 30212391
[TBL] [Abstract][Full Text] [Related]
42. Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma.
Chen FP; Luo YS; Chen K; Li JY; Huo LQ; Shi L; Ou-Yang Y; Cao XP
Eur J Cancer; 2021 Jul; 151():63-71. PubMed ID: 33964573
[TBL] [Abstract][Full Text] [Related]
43. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
[TBL] [Abstract][Full Text] [Related]
44. Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang X; Zhou Z; Feng Q; Chen D; Liang J; Fang D; Mao Y; Gao S; Li Y; He J
Oncotarget; 2016 Aug; 7(34):55211-55221. PubMed ID: 27487146
[TBL] [Abstract][Full Text] [Related]
45. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes.
Hiniker SM; Roux A; Murphy JD; Harris JP; Tran PT; Kapp DS; Kidd EA
Gynecol Oncol; 2013 Nov; 131(2):380-5. PubMed ID: 23954572
[TBL] [Abstract][Full Text] [Related]
46. Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.
Shu T; Zhao D; Li B; Wang Y; Liu S; Li P; Zuo J; Bai P; Zhang R; Wu L
Chin J Cancer Res; 2017 Dec; 29(6):510-520. PubMed ID: 29353973
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging.
Levine MD; Brown J; Crane EK; Tait DL; Naumann RW
J Minim Invasive Gynecol; 2021 Apr; 28(4):824-828. PubMed ID: 32730990
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment Factors Associated with Recurrence for Patients with Cervical Cancer International Federation of Gynecology and Obstetrics Stage IB1 Disease.
Liu SC; Huang EY; Hu CF; Ou YC; ChangChien CC; Wang CJ; Tsai CC; Fu HC; Wu CH; Lin H
Gynecol Obstet Invest; 2016; 81(4):339-45. PubMed ID: 26580917
[TBL] [Abstract][Full Text] [Related]
50. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
[TBL] [Abstract][Full Text] [Related]
51. Hazard Ratio Analysis of Laparoscopic Radical Hysterectomy for IA1 With LVSI-IIA2 Cervical Cancer: Identifying the Possible Contraindications of Laparoscopic Surgery for Cervical Cancer.
Li P; Liu P; Yang Y; Wang L; Liu J; Bin X; Lang J; Chen C
Front Oncol; 2020; 10():1002. PubMed ID: 32733796
[No Abstract] [Full Text] [Related]
52. Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real-world multicenter study of a large Chinese cohort from 2006 to 2017.
Guo C; Tang X; Meng Y; Zhang Y; Zhang X; Guo J; Lei X; Qiu J; Hua K
Cancer Med; 2020 Aug; 9(16):5908-5921. PubMed ID: 32628356
[TBL] [Abstract][Full Text] [Related]
53. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
54. Laparoscopic vs. Abdominal Radical Hysterectomy for Locally Advanced Cervical Cancer.
Wang W; Li L; Wu M; Ma S; Tan X; Zhong S
Front Oncol; 2019; 9():1331. PubMed ID: 31828044
[TBL] [Abstract][Full Text] [Related]
55. Expression and prognostic significance of TAp73 and ΔNp73 in FIGO stage I-II cervical squamous cell carcinoma.
Zhu W; Pan X; Yang Z; Xing P; Zhang Y; Li F; Lu X
Oncol Lett; 2015 May; 9(5):2090-2094. PubMed ID: 26137018
[TBL] [Abstract][Full Text] [Related]
56. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
57. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis.
Li H; Yang Y; Zhou H; Liu F; Li M; Chen L; Wu X; Cheng X
Transl Cancer Res; 2019 Aug; 8(4):1217-1223. PubMed ID: 35116863
[TBL] [Abstract][Full Text] [Related]
59. Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y; Li Z; Kang S; Yang Y; Ling B; Wang L; Yao J; Li P; Wang X; Gong S; Fan H; Kong Y; Cao Y; Lang J; Liu P; Chen C
BMC Cancer; 2023 May; 23(1):421. PubMed ID: 37161372
[TBL] [Abstract][Full Text] [Related]
60. Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer.
Xu M; Xie X; Cai L; Xie Y; Gao Q; Sun P
Front Oncol; 2022; 12():809159. PubMed ID: 35433446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
